Seres Therapeutics (MCRB) Misses Q1 EPS by 2c
Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.57), $0.02 worse than the analyst estimate of ($0.55).
For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.
Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.57), $0.02 worse than the analyst estimate of ($0.55).
For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.